Rhenman & Partners Asset Management’s STAAR Surgical STAA Stock Holding History

Rhenman & Partners Asset Management’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-65,000	Closed	-$3.09M	–	98
2024 Q2	$3.09M	Buy	+65,000	New	+$2.85M	0.3%	70
2018 Q2	–	Sell	-24,658	Closed	-$365K	–	90
2018 Q1	$365K	Sell	24,658 -51,598	-68%	-$806K	0.05%	87
2017 Q4	$1.18M	Sell	76,256 -13,744	-15%	-$204K	0.16%	78
2017 Q3	$1.12M	Buy	90,000 +20,050	+29%	+$224K	0.14%	78
2017 Q2	$755K	Buy	69,950 +41,239	+144%	+$403K	0.11%	86
2017 Q1	$281K	Hold	28,711	–	–	0.04%	98
2016 Q4	$312K	Buy	+28,711	New	+$292K	0.06%	94

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rhenman & Partners Asset Management's STAA Position: Q3 2024 in Review

Rhenman & Partners Asset Management sold out of STAAR Surgical (STAA) in Q3 2024, closing a stake of 65,000 shares — an estimated $3.09M sold.

Rhenman & Partners Asset Management first reported a position in STAA in Q4 2016 and held it in 7 quarters. The position peaked at $3.09M in Q2 2024. 236 funds tracked by Wall St. Rank hold STAA as of Q3 2024.

Rhenman & Partners Asset Management reported no remaining STAAR Surgical position as of Q3 2024 after selling out during the quarter.
Rhenman & Partners Asset Management sold 65,000 STAAR Surgical shares in Q3 2024, an estimated $3.09M.
Rhenman & Partners Asset Management first reported a position in STAAR Surgical in Q4 2016 and held it in 7 quarters.
Rhenman & Partners Asset Management's STAAR Surgical position peaked at $3.09M in Q2 2024.
236 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2024.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.